Hadassah follows US centers in implanting embryonic stem cell for optical … – Jerusalem Post Israel News
Jerusalem Post Israel News |
Hadassah follows US centers in implanting embryonic stem cell for optical …
Jerusalem Post Israel News Following several attempts by US researchers, ophthalmologists at the Hadassah University Medical Center in Jerusalem’s Ein Kerem have become the first in Israel to implant retinal-pigment epithelial (RPE) cells derived from embryonic stem cells into a … |
Jerusalem Post Israel News |
Hadassah follows US centers in using embryonic stem cell for optical procedures
Jerusalem Post Israel News Following several attempts by US researchers, ophthalmologists at the Hadassah University Medical Center in Jerusalem’s Ein Kerem have become the first in Israel to implant retinal-pigment epithelial (RPE) cells derived from embryonic stem cells into a … |
Hamilton Spectator |
Health minister ‘aware’ of delays in stem cell treatment
Hamilton Spectator A Burlington teen raising alarms about cancer patients getting unnecessary chemotherapy treatments because of long waits for stem cell transplants has caught the attention of Ontario’s health minister. “I’m very much aware,” Dr. Eric Hoskins said … |
Horsetalk |
New NY lab for equine stem cell specialists
Horsetalk MediVet’s Manhattan laboratory will focus on commercially producing and clinically testing an allogeneic stem cell therapy product that has the potential for orthopedic and internal medicine applications for both veterinary and human clinical use … |
|
Scientist and Stem Cell Expert Says Don’t Be…
Aleteia EN She was the first person to discover adult cardiac derived stem cells, and has been a champion of adult stem cell research for two decades. She is also founder of AVM Biotechnology, which is dedicated to the discovery, development, and … |
|
Scientist and Stem Cell Expert Says Don’t Be…
Aleteia EN She was the first person to discover adult cardiac derived stem cells, and has been a champion of adult stem cell research for two decades. She is also founder of AVM Biotechnology, which is dedicated to the discovery, development, and … |
Nature.com |
Cancer: Repositioned to kill stem cells
Nature.com The persistence of quiescent (dormant, non-cycling) and thus drug-resistant leukaemic stem cells (LSCs) poses an unmet clinical challenge, and any attempt to cure CML must target the eradication of these cells. In a paper on Nature’s website, Prost et al. |